iCureASPS Continues to Support ASPS Research in the Laboratory of Dr. Dina Lev at MD Anderson Cancer Center, TX
In April 2008, iCureASPS started to support the research of Dr. Dina Lev, MD, on Alveolar Soft Part Sarcoma. Dr. Dina Lev is Assistant Professor at the Sarcoma Research Center, MD Anderson Cancer Center, Houston Texas. In November 2008, iCureASPS donated an additional $5,000 to her laboratory. Dr. Lev published a study on angiogenesis-promoting genes in […]
Research sponsored by iCureASPS published: Is ASPS a target for Halofuginone therapy?
Cure Alveolar Soft Part Sarcoma International is very proud to announce the publication of a study that was supported by donations through our organization. The new study appears in the scientific journal ”Neoplasia”. It focuses on genes which are expressed in alveolar soft part sarcoma and in the normal cells surrounding the tumor. Those cells […]
iCureASPS supports ASPS Research in the laboratory of Dr. Dina Lev at MD Anderson Cancer Center
iCureASPS is looking for active members of the ASPS community to help maintaining viable collaborations with scientists who perform ASPS research in medical centers. If you wish to be part of an active search for Alveolar Soft Part Sarcoma Cure, please contact us! Such a new collaboration was recently established with Dr. Dina Lev at […]
iCureASPS Sponsors Studies on Halofuginone, a Possible Therapy for Alveolar Soft Part Sarcoma
iCureASPS has recently sent funds to sponsor an original research, which is carried out in the laboratory of Dr. Mark Pines at the Volcani Center, Bet Dagan, Israel. Halofuginone is an analog of the molecule febrifugine. Febrifugine is the active component in the extract from the roots of the Chinese herb chang shan (Dichroa febrifuga), […]
Two New Research Studies on Alveolar Soft Part Sarcoma
Two scientific publications on Alveolar Soft Part Sarcoma have been recently published: “Angiogenesis-promoting gene patterns in Alveolar Soft Part Sarcoma” by Lazar et al., 2007 (from M. D. Anderson Cancer Center) and “Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of Alveolar Soft Part Sarcoma” by Vistica et al., 2008 (from The National Cancer Center). Lazar […]
iCureASPS Supports Three Clinical Projects at the Dana Farber Cancer Institute
Cure Alveolar Soft Part Sarcoma (iCureASPS) is currently supporting three initiatives that hopefully will bring us closer to the day when a cure for Alveolar Soft Part Sarcoma is a reality. Here is a progress report on those projects. 1. The GVAX clinical trial – Opened on January 2006, the first cancer vaccine trial for […]
Alveolar soft-part sarcoma: scientific review and update / November 2006
Written by Folpe AL and Deyrup AT at the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA. Alveolar soft-part sarcoma (ASPS) is a rare, distinctive sarcoma, typically occurring in young patients. Although it displays a relatively indolent clinical course, the ultimate prognosis is poor and is often characterised by late metastases. Recently, […]